Cargando…

Staging Anti-Inflammatory Therapy in Alzheimer's Disease

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease (AD) is controversial because conclusions from numerous epidemiological studies reporting delayed onset of AD in NSAID users have not been corroborated in clinical trials. The purpose of this personal view is to re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lichtenstein, Mathieu P., Carriba, Paulina, Masgrau, Roser, Pujol, Aurora, Galea, Elena
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998033/ https://www.ncbi.nlm.nih.gov/pubmed/21152343 http://dx.doi.org/10.3389/fnagi.2010.00142

Ejemplares similares

Amyloid Beta, TNFα and FAIM-L; Approaching New Therapeutic Strategies for AD
por: Carriba, Paulina, et al.
Publicado: (2014)

CD40 is a major regulator of dendrite growth from developing excitatory and inhibitory neurons
por: Carriba, Paulina, et al.
Publicado: (2017)

Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging
por: Liu, Sidong, et al.
Publicado: (2016)

Resting State Networks in the TgF344-AD Rat Model of Alzheimer’s Disease Are Altered From Early Stages
por: Tudela, Raúl, et al.
Publicado: (2019)

Inflammatory process in Alzheimer's Disease
por: Meraz-Ríos, Marco A., et al.
Publicado: (2013)

Neuroprotective effects of Morinda officinalis How.: Anti-inflammatory and antioxidant roles in Alzheimer’s disease
por: Zhang, Yi, et al.
Publicado: (2022)

The Role of Magnetoencephalography in the Early Stages of Alzheimer’s Disease
por: López-Sanz, David, et al.
Publicado: (2018)

Top-Down Proteomics of Human Saliva Highlights Anti-inflammatory, Antioxidant, and Antimicrobial Defense Responses in Alzheimer Disease
por: Contini, Cristina, et al.
Publicado: (2021)

Corrigendum: Top-Down Proteomics of Human Saliva Highlights Anti-inflammatory, Antioxidant, and Antimicrobial Defense Responses in Alzheimer Disease
por: Contini, Cristina, et al.
Publicado: (2021)

Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?
por: Karunaweera, Niloo, et al.
Publicado: (2015)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
por: Rivers-Auty, Jack, et al.
Publicado: (2020)

Ketamine: A Neglected Therapy for Alzheimer Disease
por: Smalheiser, Neil R.
Publicado: (2019)

Exercise therapy to prevent and treat Alzheimer’s disease
por: Pahlavani, Hamed Alizadeh
Publicado: (2023)

CREB Regulates Distinct Adaptive Transcriptional Programs in Astrocytes and Neurons
por: Pardo, Luis, et al.
Publicado: (2017)

The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer’s disease phenotype
por: Joshi, Yash B., et al.
Publicado: (2015)

The relationship between Alzheimer’s disease and intestinal microflora structure and inflammatory factors
por: Wang, Su-shan, et al.
Publicado: (2022)

Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
por: Santiago, Jose A., et al.
Publicado: (2019)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
por: Hector, Audrey, et al.
Publicado: (2021)

Afferent and Efferent Visual Markers of Alzheimer’s Disease: A Review and Update in Early Stage Disease
por: Wu, Shirley Z., et al.
Publicado: (2020)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

How CD40L reverse signaling regulates axon and dendrite growth
por: Carriba, Paulina, et al.
Publicado: (2020)

Signalling Pathways Mediating the Effects of CD40-Activated CD40L Reverse Signalling on Inhibitory Medium Spiny Neuron Neurite Growth
por: Carriba, Paulina, et al.
Publicado: (2021)

CD40L/CD40 bidirectional signaling is a major regulator of neuronal morphology in the developing nervous system
por: Carriba, Paulina, et al.
Publicado: (2021)

Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer’s disease
por: Plaza-Rosales, Iván, et al.
Publicado: (2023)

Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
por: Mitra, Sumonto, et al.
Publicado: (2019)

The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease
por: Culibrk, Robert A., et al.
Publicado: (2020)

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
por: Fiandaca, Massimo S., et al.
Publicado: (2015)

Altered Homotopic Functional Connectivity Within White Matter in the Early Stages of Alzheimer’s Disease
por: Wang, Pan, et al.
Publicado: (2021)

A Two-Stage Model for Predicting Mild Cognitive Impairment to Alzheimer’s Disease Conversion
por: Lu, Peixin, et al.
Publicado: (2022)

Mitochondrial Deficits With Neural and Social Damage in Early-Stage Alzheimer’s Disease Model Mice
por: Misrani, Afzal, et al.
Publicado: (2021)

Attention and Functional Connectivity Among Patients With Early-Stage Subcortical Ischemic Vascular Disease and Alzheimer’s Disease
por: Tu, Min-Chien, et al.
Publicado: (2020)

The Quest for an Alzheimer Therapy
por: Cappa, Stefano F.
Publicado: (2018)

Disruption of Glucose Metabolism in Aged Octodon degus: A Sporadic Model of Alzheimer's Disease
por: Cisternas, Pedro, et al.
Publicado: (2021)

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
por: Nava-Mesa, Mauricio O., et al.
Publicado: (2014)

Brain and Retinal Abnormalities in the 5xFAD Mouse Model of Alzheimer's Disease at Early Stages
por: Zhang, Mengrong, et al.
Publicado: (2021)

Prefrontal EEG slowing, synchronization, and ERP peak latency in association with predementia stages of Alzheimer’s disease
por: Choi, Jungmi, et al.
Publicado: (2023)

Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions
por: Walker, Douglas, et al.
Publicado: (2007)

Periodontitis and Alzheimer’s Disease: A Possible Comorbidity between Oral Chronic Inflammatory Condition and Neuroinflammation
por: Teixeira, Francisco B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qr4a357p3163ocd4fklck0jpko